ANTIANGIOGENIC GENE THERAPY WITH SOLUBLE VEGFR-2 AND TIE2 REDUCES THE GROWTH OF HUMAN OVARIAN CARCINOMA IN MICE

被引:0
|
作者
Tuppurainen, L. [1 ]
Sallinen, H. [2 ]
Karvonen, A. [1 ]
Hakkarainen, H. [3 ]
Liimatainen, T. [3 ]
Hytonen, E. [1 ]
Hamalainen, K. [4 ]
Kosma, V. M. [4 ]
Anttila, M. [2 ]
Alitalo, K. [5 ,6 ]
Yla-Herttuala, S. [1 ]
机构
[1] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Biotechnol & Mol Med, Kuopio, Finland
[2] Kuopio Univ Hosp, Dept Gynecol, SF-70210 Kuopio, Finland
[3] Univ Eastern Finland, NMR Res Grp, AI Virtanen Inst Mol Sci, Kuopio, Finland
[4] Kuopio Univ Hosp, Dept Pathol, SF-70210 Kuopio, Finland
[5] Univ Helsinki, Mol Canc Biol Lab, Biomedicum Helsinki, Helsinki, Finland
[6] Univ Helsinki, Haartman Inst, Helsinki, Finland
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ESGO-1277
引用
收藏
页码:636 / 636
页数:1
相关论文
共 50 条
  • [21] Expression of angiopoietin-2 gene and its receptor Tie2 in hepatocellular carcinoma
    Chen, Libo
    Yang, Zhen
    Wang, Guobin
    Wang, Chunyou
    Journal of Huazhong University of Science and Technology - Medical Science, 2001, 21 (03): : 228 - 230
  • [22] Expression of Angiopoietin-2 Gene and Its Receptor Tie2 in Hepatocellular Carcinoma
    陈立波
    杨镇
    王国斌
    王春友
    JournalofTongjiMedicalUniversity, 2001, (03) : 228 - 230
  • [23] Inhibition of angiogenesis by a Semliki Forest virus vector expressing VEGFR-2 reduces tumour growth and metastasis in mice
    J A Lyons
    B J Sheahan
    S E Galbraith
    R Mehra
    G J Atkins
    M N Fleeton
    Gene Therapy, 2007, 14 : 503 - 513
  • [24] Cellular expression of vascular endothelial growth factor receptor-2 (VEGFR-2) indicates potential non-angiogenic roles for VEGFR-2 in spermatogenesis and ovulation in VEGFR-2 lacZ mice.
    Clopton, DT
    Bott, RC
    McFee, RM
    Cupp, AS
    BIOLOGY OF REPRODUCTION, 2004, : 244 - 244
  • [25] Inhibition of angiogenesis by a Semliki Forest virus vector expressing VEGFR-2 reduces tumour growth and metastasis in mice
    Lyons, J. A.
    Sheahan, B. J.
    Galbraith, S. E.
    Mehra, R.
    Atkins, G. J.
    Fleeton, M. N.
    GENE THERAPY, 2007, 14 (06) : 503 - 513
  • [26] Administration of human chorionic gonadotropin (hCG) alters cellular expression of vascular endothelial growth factor receptor-2 (VEGFR-2) in the testes of VEGFR-2 lacz mice.
    Clopton, DT
    Bott, RC
    Ten Broeck, RA
    Tepfer, AJ
    Baltes, MM
    Schulz, JS
    Cupp, AS
    BIOLOGY OF REPRODUCTION, 2005, : 177 - 178
  • [27] Vascular endothelial growth factor receptor-2 (VEGFR-2) gene variations in bronchioloalveolar cell carcinoma (BAC)
    Cerri, Elisa
    Kashyap, Sonal
    Chen, Pei Xian
    Das, Soma
    Cipriani, Nicole
    Kanteti, Rajani
    Husain, Aliya
    Salgia, Ravi
    Innocenti, Federico
    CANCER RESEARCH, 2010, 70
  • [28] Angiopoietin2 and Tie2: Tied to Lymphangiogenesis and Lung Metastasis. New Perspectives in Antimetastatic Antiangiogenic Therapy
    Albini, Adriana
    Noonan, Douglas M.
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (06) : 429 - 431
  • [29] Adjunctive therapy with the Tie2 agonist Vasculotide reduces pulmonary permeability in Streptococcus pneumoniae infected and mechanically ventilated mice
    Lask, Aina
    Gutbier, Birgitt
    Kershaw, Olivia
    Nouailles, Geraldine
    Gruber, Achim D.
    Muller-Redetzky, Holger C.
    Chackowicz, Steven
    Hamilton, Douglas A.
    Van Slyke, Paul
    Witzenrath, Martin
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [30] Adjunctive therapy with the Tie2 agonist Vasculotide reduces pulmonary permeability in Streptococcus pneumoniae infected and mechanically ventilated mice
    Aina Lask
    Birgitt Gutbier
    Olivia Kershaw
    Geraldine Nouailles
    Achim D. Gruber
    Holger C. Müller-Redetzky
    Steven Chackowicz
    Douglas A. Hamilton
    Paul Van Slyke
    Martin Witzenrath
    Scientific Reports, 12